Top Markets
Coin of the day
Nuformix plc Nuformix plc

Nuformix plc

NFX
주식 순위 #41013
Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes... Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes in developing therapies for fibrotic diseases and cancer, primarily through the innovative strategy of drug repurposing. Its current development portfolio includes NXP001, which has advanced beyond Phase 1 trials for application in oncology supportive care. Additionally, the company is progressing NXP004, a novel variant of Olaparib, currently in its intellectual property generation stage for oncological indications, and NXP002, which is undergoing pre-clinical evaluation for the treatment of idiopathic pulmonary fibrosis. Nuformix also holds an option agreement with Oxilio Ltd. concerning NXP001 for its oncology applications. Established in 2008, the company maintains its operational base in London.
주가
$0.00185055
시가총액
$48.29K
변동 (1일)
-3.55%
변동 (1년)
30.31%
국가
GB
거래 Nuformix plc (NFX)

카테고리

Nuformix plc (NFX)의 배당 수익률 기록
Nuformix plc (주식 심볼: NFX)의 배당 수익률 (TTM)은 2024-09-30 기준으로 0.00%입니다.
지난 5년 평균 배당 수익률: 0.00%
Nuformix plc (NFX)의 배당 수익률 기록: 2014 ~ 2026
연도별 말 기준 배당 수익률 (TTM)
연도 배당 수익률 변화
2026 (TTM) 0.00% 0.00%
2025 0.00% 0.00%
2024 0.00% 0.00%
2023 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
2018 0.00% 0.00%
2017 0.00% 0.00%
2016 0.00% 0.00%
2014 0.00% 0.00%
유사 기업 또는 경쟁사의 배당 수익률 (TTM)
회사 배당 수익률 국가
0.00%
US
0.00%
US
2.36%
AU
0.00%
NL
0.00%
CH